Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive

about

Alivus Life Sciences Ltd. (formerly Glenmark Life Sciences Ltd.) is a manufacturer and developer of high-value, non-commoditized Active Pharmaceutical Ingredients (APIs). The company focuses on chronic therapeutic areas, including cardiovascular dise...

1070.30 10.30 (0.97%)

30.68% Gain from 52W Low

112.3K

NSE+BSE Volume

NSE 19 Jun, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

65.8 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

1Yr Price target upside is 15%

Alivus Life Sciences Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

133 Votes:

Buy 75.19%

Sell 12.03%

Hold 12.78%

×